Implementing a clinical pharmacy survey of adverse drug events in a French emergency department

被引:0
|
作者
Lucien Roulet
Nathalie Asseray
Martin Dary
Anne Chiffoleau
Gilles Potel
Françoise Ballereau
机构
[1] Teaching Hospital,Emergency Department
[2] UPRES EA 3826,Faculty of Medical Sciences
[3] Teaching Hospital,Department of Clinical Pharmacology
[4] Teaching Hospital,Medqual
关键词
Adverse drug event; CPSA; Emergency department; France; Pharmacoepidemiology; Survey;
D O I
暂无
中图分类号
学科分类号
摘要
Background The prevalence of adverse drug events (ADEs) occurring in the ambulatory setting is high, requiring the development of a coherent and comprehensive patient-safety policy framework. Former experiences demonstrated that emergency department (ED) surveillance can help characterise the burden of outpatient ADEs. We developed a clinical pharmacy programme called the clinical pharmacy survey of adverse drug events (CPSA) to support interventions and research projects in the area of ADE prevention and management. Objective To design a survey to identify and describe ADEs in patients visiting the medical ED of our tertiary care hospital. We report the results of the first 2 years of CPSA implementation and an assessment of its performance. Setting The medical ED of a French 3,000-bed tertiary care hospital. Method Between January 2008 and December 2009, adult patients visiting our medical ED were included during randomised time slots. Data were collected by pharmacy students. ADEs were documented by a trained physician pharmacist team using the chart review method. Main outcome measure The primary outcome was the number of patients visiting our ED with an ADE. The CPSA attributes were assessed on the basis of the Centers for Disease Control and Prevention’s 2001 updated guidelines for evaluating public health surveillance systems. Results Of the 1,035 included patients, 201 experienced an ADE at the ED visit (19.4 %; 95 % confidence interval 15.8–23.0 %). Forty-seven ADEs (23.4 %) were unrelated to the patient’s chief complaint. An ADE was the leading cause of 154 in the 1,035 admissions (14.9 %). The assessment of our method on the basis of the Centers for Disease Control and Prevention guidelines showed good performances in terms of data quality, stability, flexibility, timeliness, and acceptability, but not in terms of simplicity and representativeness. The profile of patients with an ADE at admission and detected ADEs did not significantly differ between years 2008 and 2009. Conclusion Our experience demonstrates that clinical pharmacists can successfully implement a survey process of ADEs in an ED over time. Our method seems basic enough to suit most health care facilities with pharmacy students.
引用
收藏
页码:902 / 910
页数:8
相关论文
共 50 条
  • [31] Suspected adverse drug events requiring emergency department visits or hospital admissions
    R. Raschetti
    M. Morgutti
    F. Menniti-Ippolito
    A. Belisari
    A. Rossignoli
    P. Longhini
    C. La Guidara
    [J]. European Journal of Clinical Pharmacology, 1999, 54 : 959 - 963
  • [32] Involvement of addictovigilance in a program of detection of adverse drug events at an Emergency department (URGEIM)
    Serre, A.
    Eiden, C.
    Gourant, V.
    Perrier, D.
    Sebbane, M.
    Giraud, I.
    Peyriere, H.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 39 - 39
  • [33] Adverse Drug Events Leading Children to Emergency Department, Sao Paulo, Brazil
    Romano-Lieber, Nicolina S.
    Ribeiro, Eliane
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S320 - S321
  • [34] Drug-induced adverse events in elderly persons presenting to the emergency department
    Martin-Sanchez, Francisco Javier
    Martinez Agueero, Maria
    Fernandez Alonso, Cesareo
    Gonzalez del Castillo, Juan
    Gonzalez Armengol, Juan Jorge
    [J]. GACETA SANITARIA, 2012, 26 (06) : 585 - 585
  • [35] Suspected adverse drug events requiring emergency department visits or hospital admissions
    Raschetti, R
    Morgutti, M
    Menniti-Ippolito, F
    Belisari, A
    Rossignoli, A
    Longhini, P
    La Guidara, C
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 54 (12) : 959 - 963
  • [36] Regional surveillance of emergency-department visits for outpatient adverse drug events
    Capuano, A.
    Irpino, A.
    Gallo, M.
    Ferrante, L.
    Illiano, M. L.
    Rinaldi, B.
    Filippelli, A.
    Rossi, F.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (07) : 721 - 728
  • [37] Impact of a pharmaceutical presence on adverse drug reaction notification in a French emergency department
    Roulet, L.
    Asseray, N.
    Chiffoleau, A.
    Potel, G.
    Ballereau, F.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 84 - 84
  • [38] Adverse events following an emergency department visit
    Forster, Alan J.
    Rose, Nicholas G. W.
    van Walraven, Carl
    Stiell, Ian
    [J]. QUALITY & SAFETY IN HEALTH CARE, 2007, 16 (01): : 17 - 22
  • [39] Adverse events of emergency department procedural sedation
    Mace, S. E.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2006, 48 (04) : S59 - S59
  • [40] Emergency Department Adverse Events Detected Using the Emergency Department Trigger Tool
    Griffey, Richard T.
    Schneider, Ryan M.
    Todorov, Alexandre A.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2022, 80 (06) : 528 - 538